Clinical Trial Update: A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigated different doses of bone marrow–derived mesenchymal stem cells in patients with critical limb ischemia due to Buerger's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Buerger Disease
• Critical Limb Ischemia

Drugs mentioned

• Bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Stempeutics Research Pvt Ltd | Conditions: Critical Limb Ischemia, Buerger's Disease | Phase 2 | Status: COMPLETED